A fresh outbreak of Ebola is tearing through the Democratic Republic of Congo, with sources on the ground confirming the death toll is climbing faster than officials will admit. The World Health Organization’s director general touched down in Kinshasa this morning for a photo-op, but the real story is unfolding in remote villages where medics are overwhelmed and body bags are running out.
Uncovered documents from aid groups show that the current wave has already infected over 200 people, with a fatality rate pushing 60 per cent. The Congolese health ministry is downplaying the numbers, but I’ve spoken to nurses who say they’re burying five people a day in mass graves. The WHO chief looked grim at the press conference, flanked by local politicians in crisp suits, offering “coordination and support” – but no one mentioned the budget cuts that gutted the country’s disease surveillance last year.
Meanwhile, Downing Street has announced a £10 million emergency aid package for the region. The UK’s Foreign Office says the money will fund mobile testing labs and protective equipment. Noble words, but let’s not pretend this is charity. Britain’s own biosecurity depends on containing outbreaks at the source, and the pharmaceutical giants are already circling. I’ve seen the contracts: the real prize is the vaccine data.
The virus is spreading along trade routes, hitting mining towns where workers live in cramped, unsanitary conditions. This is a corporate disaster waiting to happen. Global supply chains are fragile, and the same companies that exploit Congolese cobalt are about to face a reckoning. Don’t expect them to pay for the clean-up.
This is a countdown. The WHO will declare a public health emergency within days. The UK will send more money. And the suits will gather in Geneva to discuss “lessons learned” while the body count rises. Follow the money. You’ll find the bodies.
